Overview

Comparability DE vs CD-CHO1

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
Study to Compare the Pharmacokinetics of CD-CHO1 Process BMS-188667 to DE Process BMS-188667 in Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Abatacept